Quantcast

Latest S. aureus Stories

2012-04-25 20:30:24

Antibiotic-resistant bacteria continue to be a global concern with devastating repercussions, such as increased healthcare costs, potential spread of infections across continents, and prolonged illness.

Mass Spectrometry Rapidly Detects Staph Infections
2012-01-13 04:12:37

Researchers from the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) have developed a new laboratory test that can rapidly identify the bacterium responsible for staph infections.

2011-07-20 05:00:00

WAYNE, Pa. and PETACH TIKVA, Israel, July 20, 2011 /PRNewswire/ -- Molecular Detection Inc.

2011-07-01 17:04:00

SAN DIEGO, July 1, 2011 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced that it has received an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Institute of Allergy and Infectious Diseases.

bfda2e480179b6d448c10c97b647c985
2011-06-02 08:58:20

MRSA transmission may be occurring in fire stations, according to a study published in the June issue of the American Journal of Infection Control.

2011-05-06 12:50:00

SILVER SPRING, Md., May 6, 2011 /PRNewswire-USNewswire/ -- The U.S.

2011-04-28 07:00:00

CHAPEL HILL, N.C., April 28, 2011 /PRNewswire/ -- Researchers from the Hershey Medical Center today announced the publication of research demonstrating that the antibiotic, fusidic acid, is active against MRSA strains isolated from cystic fibrosis (CF) patients.

b81a1e60fc764225057c0ee5dbec80fb1
2011-04-12 05:55:00

A new study suggests that people who use certain prescribed antibiotics for treatment of acne are unlikely to develop bacteria resistance to those drugs, even when they use the antibiotics for months at a time.

2011-04-11 22:13:30

The prolonged use of tetracycline antibiotics commonly used to treat acne was associated with a reduced prevalence of StaphylococcuS.

2011-04-11 01:32:00

WHITEHOUSE STATION, N.J., and VIENNA, April 11, 2011 /PRNewswire/ -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Intercell AG (VSE: ICLL) today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus (S.


Latest S. aureus Reference Libraries

72_eee8f4e550996ac6ae01af15eddb314c
2011-04-26 20:20:41

Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...

More Articles (1 articles) »
Word of the Day
shavie
  • A trick or prank.
The word 'shavie' is related to 'shave'.